Strategy development, clinical trials management, data
Management, biostatistical analysis, regulatory affairs, medical
marketing, training, publishing and advanced technology.
Overview
PAREXEL INTERNATIONAL (ISRAEL) LTD. was established in 1996 by
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
acquiring Lansal Clinical Pharmaceutics Ltd., a full-service CRO
in Tel Aviv, Israel.
In 1997 the company divided its operations into three strategic
business units: Clinical Research Services, Medical Marketing
Services and Consulting Services to better service clients and
capitalize on market opportunities.
PAREXEL provides high quality, cost-effective, comprehensive, and
globally integrated services to develop and commercialize the
products of the clients throughout the world in the
pharmaceutical, biotechnology, medical device and other
healthcare industries. PAREXEL is committed to a Best Value
customer focus; delivering expertise, quality, flexibility and
client satisfaction.
PAREXEL International has played a key role in the
pharmaceutical, biotechnology and medical device industries by
partnering with clients to accelerate time-to-market, control
development costs, reduce risk, and maximize return on
investment. As one of the largest pharmaceutical services
companies in the world, PAREXEL delivers a full range of services
and solutions through its offices in 35 countries.
